Funding profile · Health benefits (ICHRA)

Thatch

About $192.5 million in equity announced across four financings, a $1 billion valuation in September 2026 set by existing investors, data vendors that disagree on the Series C, and no Form D under the company’s name.

$192.5MTotal equity reported through the Series C (Sep 2026)
$1BSeries C post-money valuation, company-reported
$410MSeries B valuation, PitchBook via TechCrunch
5,000+Employers on the platform, company-reported (Sep 2026)

Data as of November 11, 2026. Company-reported figures are labeled. Valuations are as announced or as reported by data vendors and are not confirmed by any filing.

Rounds at a glance

When Round Amount Investors Source
Feb 2023 Pre-seed and seed Over $6M total, including a $5.6M seed Seed co-led by Andreessen Horowitz and GV; Lux Capital, Quiet Capital, Not Boring Capital, BrightEdge Company release
Sep 2024 Series A $38M Led by Index Ventures and General Catalyst; SemperVirens, The General Partnership; Andreessen Horowitz and Avid Ventures returning Company release
Apr 2025 Series B $40M at a reported $410M valuation Led by Index Ventures; Andreessen Horowitz, General Catalyst, SemperVirens, PeopleTech Partners, The General Partnership; ADP Ventures new Company release
Apr 2026 Venteur customer transition Terms not disclosed Employers, employees and brokers served by Venteur moving to Thatch Company-stated
Sep 2026 Series C $108M at a $1B post-money valuation The General Partnership, Index Ventures, General Catalyst, Andreessen Horowitz; ADP Ventures, Paychex, Eli Lilly and Company, Scale Venture Partners, QuantumLight, SemperVirens, Quiet Capital Company release
2026 Series C, vendor records $69.9M at $647.1M (Dealroom); $130M at $1.03B in April (Forge) Not reconciled with the company’s figures Conflict

What the filings show

Thatch Health, Inc. · Form D search · checked Nov 11, 2026

Result
No Form D located for any round
Searched
EDGAR full-text search of Form D filings for “Thatch Health”, “Thatch” and the founders’ names, plus the EDGAR company index
Name collision
The only Form D filer with the name is Thatch Group Fund, LLC (CIK 0002032831), a pooled investment fund based in Orem, Utah, with no overlap in related persons. It is unrelated.
Implication
None of the roughly $192.5 million announced appears on the SEC record under this name

Reading the filings

  1. Four financings and no notice on file.As with several venture-backed health companies, Thatch’s rounds appear in press releases and data vendors but not in EDGAR under its legal name. Raising under Section 4(a)(2), or through an entity with another name, would explain it. The absence is a disclosure gap, not evidence of wrongdoing.
  2. Three vendors, three different Series C rounds.The company and TechCrunch report $108 million at a $1 billion valuation in September 2026. Dealroom lists $69.9 million at $647.1 million. Forge lists $130 million at $1.03 billion in April. Staged closings or a tranche structure could account for some of the difference. Without a filing, none can be confirmed.
  3. The insiders set the price.TechCrunch reported that the $108 million came from existing investors, and the company did not name a single lead. Insider rounds signal conviction, but they also mean no new lead tested the $1 billion price.
  4. The strategic investors are distribution, plus one surprise.ADP joined at the Series B and embedded Thatch in its payroll workflow; Paychex joined at the Series C. Both are payroll channels into small and mid-size employers. Eli Lilly’s participation is unusual for a benefits platform and worth watching.
  5. The valuation rose about 2.4 times in 17 months.From a reported $410 million at the April 2025 Series B to $1 billion in September 2026. The company says annual recurring revenue grew about seven times over the past year, and it reported 8x year-over-year revenue growth at the Series B.
  6. The business rides on a regulation.Thatch is built on individual coverage HRAs, a federal arrangement first allowed for plan years beginning in 2020 and now also referred to as CHOICE arrangements. Rule changes in Washington could expand or shrink the market quickly.

Commercial signals

Signal Detail Source type
Customers More than 5,000 employers as of September 2026, up from more than 1,000 companies at the April 2025 Series B. Company-stated
Growth Annual recurring revenue up about seven times over the past year. Revenue not disclosed. Unaudited. Company-stated
Distribution ICHRA benefits embedded in ADP’s payroll platform (2025); Venteur’s employers, employees and brokers transitioning to Thatch (April 2026). Company-stated
Market Employers offering ICHRA rose from more than 6,600 in 2025 to more than 12,700 in 2026, per the HRA Council. Independent
Strategy The chief executive told ION Analytics in October 2026 that Thatch will consider acquisitions as the market consolidates. Independent

What to watch

  • Acquisitions of smaller ICHRA administrators. Competitors include Take Command, PeopleKeep, Remodel Health and Zorro.
  • Federal rule changes to ICHRA or CHOICE arrangements, the single largest swing factor for demand.
  • A reconciliation of the Series C figures, or any Form D that settles them.
  • What Eli Lilly’s stake turns into commercially.

The a16z infinite healthcare thesis, and what it means for real estateHealthcare Venture Capital Fund

Related companies

Sources

  1. Public recordEDGAR full-text search, Form D, “Thatch Health” and “Thatch”; Form D, Thatch Group Fund, LLC, CIK 0002032831SEC · checked Nov 11, 2026
  2. CompanyThatch launches with funding from a16z and GVPR Newswire · Feb 15, 2023
  3. CompanyThatch announces $38M Series A fundingCompany release · Sep 5, 2024
  4. CompanyThatch raises $40M Series B led by Index VenturesThatch · Apr 2025
  5. IndependentThatch raises $40M to give employees more control of their health insurance choicesTechCrunch · Apr 3, 2025
  6. IndependentHealth benefits platform Thatch reaches $1B valuation as healthcare costs surgeTechCrunch · Sep 15, 2026
  7. IndependentLatham & Watkins advises Thatch on US$108 million Series CLatham & Watkins · Sep 16, 2026
  8. IndependentThatch reports $108M Series C at $1B; Forge’s record disagreesRuntime Wire · Sep 2026
  9. IndependentThatch hits $1B valuation with Series CDealroom · Sep 2026
  10. IndependentThatch secures $108M, reaches $1B valuationMedCity News · Sep 2026

Compiled from SEC records, company releases and published reports as of November 11, 2026. Form D notices report offerings under Regulation D; companies raising under other exemptions may file none. Healthcare Venture Capital Fund holds no position in Thatch. This page is not an offer to sell or a recommendation to buy any security.